Kolset S O, Sakurai K, Ivhed I, Overvatn A, Suzuki S
Institute of Medical Biology, University of Tromsø, Norway.
Biochem J. 1990 Feb 1;265(3):637-45. doi: 10.1042/bj2650637.
The monoblastic cell line U-937 was cultured in the presence of C-ethyl beta-D-xyloside (E-xyl), hexyl beta-D-thioxyloside (HX-xyl), p-nitrophenyl beta-D-xyloside, phenyl beta-D-xyloside or phenyl alpha-D-xyloside. All of the beta-D-xylosides inhibited proliferation, but HX-xyl was by far the most efficient, and had a maximum effect at 1 mM concentration. The inhibitory effect of HX-xyl could be reversed; after washing, the HX-xyl-treated cells proliferated with a pattern similar to that of control cells. For more detailed analysis of the effects of beta-D-xylosides on cell proliferation and chondroitin sulphate (CS)/chondroitin sulphate proteoglycan (CSPG) structure, a comparison between the effects of E-xyl and HX-xyl was made. Treating the cells with 1 mM-HX-xyl resulted in a large increase in CS synthesis, whereas 1 mM-E-xyl had only minor effects on the rate of PG/glycosaminoglycan synthesis. Sepharose CL-6B gel chromatography of medium and cell fractions from 35S-labelled cells revealed that HX-xyl treatment resulted in the expression of only free CS chains, whereas E-xyl exposure leads to the synthesis of both large and small CSPGs, as well as some free CS chains. The expression of elevated levels of free CS chains was clearly correlated to the inhibition of proliferation. The proliferation of U-937-4, a clone of U-937 synthesizing ten times more CSPG/CS than the parent line, was equally inhibited by HX-xyl treatment. With this clone, however, there was no stimulation of CS synthesis after xyloside exposure, indicating that the elevated level of CS evident after xyloside treatment of the parent cell line is not causing the inhibition of proliferation. Furthermore, the biosynthesis of hyaluronate was shown not to be implicated in the xyloside-induced decrease in proliferation. The inhibition of proliferation observed in the presence of 1 mM-HX-xyl did not lead to differentiation of the cells into macrophage-like cells, as is observed when the cells are cultured in the presence of phorbol esters, agents also known to inhibit proliferation of U-937 cells.
单核细胞系U - 937在C - 乙基 - β - D - 木糖苷(E - 木糖)、己基 - β - D - 硫代木糖苷(HX - 木糖)、对硝基苯基 - β - D - 木糖苷、苯基 - β - D - 木糖苷或苯基 - α - D - 木糖苷存在的情况下进行培养。所有的β - D - 木糖苷均抑制增殖,但HX - 木糖的效果最为显著,在1 mM浓度时具有最大效应。HX - 木糖的抑制作用是可逆的;洗涤后,经HX - 木糖处理的细胞增殖模式与对照细胞相似。为了更详细地分析β - D - 木糖苷对细胞增殖和硫酸软骨素(CS)/硫酸软骨素蛋白聚糖(CSPG)结构的影响,对E - 木糖和HX - 木糖的作用进行了比较。用1 mM - HX - 木糖处理细胞导致CS合成大幅增加,而1 mM - E - 木糖对PG/糖胺聚糖合成速率仅有轻微影响。对来自35S标记细胞的培养基和细胞组分进行琼脂糖CL - 6B凝胶色谱分析表明,HX - 木糖处理仅导致游离CS链的表达,而E - 木糖处理则导致大小CSPG以及一些游离CS链的合成。游离CS链水平升高的表达与增殖抑制明显相关。U - 937 - 4是U - 937的一个克隆,其合成的CSPG/CS比亲本细胞系多十倍,经HX - 木糖处理后其增殖同样受到抑制。然而,对于这个克隆,木糖苷处理后没有CS合成的刺激,这表明亲本细胞系经木糖苷处理后明显升高的CS水平并非导致增殖抑制的原因。此外,透明质酸的生物合成未显示与木糖苷诱导的增殖减少有关。在1 mM - HX - 木糖存在下观察到的增殖抑制并未导致细胞分化为巨噬细胞样细胞,而当细胞在佛波酯存在下培养时会出现这种情况,佛波酯也是已知的抑制U - 937细胞增殖的试剂。